Correlation Between Aerovate Therapeutics and Mitsubishi Chemical

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Mitsubishi Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Mitsubishi Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Mitsubishi Chemical Holdings, you can compare the effects of market volatilities on Aerovate Therapeutics and Mitsubishi Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Mitsubishi Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Mitsubishi Chemical.

Diversification Opportunities for Aerovate Therapeutics and Mitsubishi Chemical

-0.7

Correlation Coefficient

Aerovate Therapeutics  Mitsubishi Chemical

Excellent diversification

The 3 months correlation between Aerovate and Mitsubishi is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Mitsubishi Chemical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mitsubishi Chemical and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Mitsubishi Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mitsubishi Chemical has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Mitsubishi Chemical go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Mitsubishi Chemical

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 11.58 times less return on investment than Mitsubishi Chemical. In addition to that, Aerovate Therapeutics is 2.78 times more volatile than Mitsubishi Chemical Holdings. It trades about 0.0 of its total potential returns per unit of risk. Mitsubishi Chemical Holdings is currently generating about 0.01 per unit of volatility. If you would invest  2,678  in Mitsubishi Chemical Holdings on October 7, 2024 and sell it today you would lose (131.00) from holding Mitsubishi Chemical Holdings or give up 4.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Mitsubishi Chemical Holdings

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Mitsubishi Chemical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mitsubishi Chemical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aerovate Therapeutics and Mitsubishi Chemical

The main advantage of trading using opposite Aerovate Therapeutics and Mitsubishi Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Mitsubishi Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mitsubishi Chemical will offset losses from the drop in Mitsubishi Chemical's long position.

The idea behind Aerovate Therapeutics and Mitsubishi Chemical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.